Is Indo US Bio-Tech overvalued or undervalued?
As of August 14, 2025, Indo US Bio-Tech is fairly valued with a PE ratio of 17.81 and strong growth potential, outperforming peers like Jain Irrigation and Bombay Super Hyb, despite a recent stock price decline.
As of 14 August 2025, the valuation grade for Indo US Bio-Tech has moved from expensive to fair. Based on the current analysis, the company appears to be fairly valued. The PE ratio stands at 17.81, the EV to EBIT ratio is 16.91, and the PEG ratio is notably low at 0.18, indicating potential for growth relative to its price.In comparison to its peers, Indo US Bio-Tech's valuation metrics are more favorable than those of Jain Irrigation, which has a significantly higher PE ratio of 103.25, and Bombay Super Hyb, which is classified as expensive with a PE ratio of 49.03. Additionally, Narmada Agrobase, another peer, is also rated as fair with a PE ratio of 21.56. Despite a recent decline in stock price, Indo US Bio-Tech has shown impressive long-term growth, with a 5-year return of 765.28%, compared to the Sensex's 112.79%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
